Absci Corp. (ABSI): Needham Sees 158% Price Potential - Focus on AI in Drug Research!
Reading Time: 3 minutes
Absci Corp. (ABSI) is a biotechnology company specializing in the development and optimization of drugs using AI and synthetic biology. Absci utilizes AI to accelerate the discovery and development of new drugs, particularly in the area of biological therapeutics (e.g., antibodies and proteins). The company combines synthetic biology and machine learning to design biological molecules more quickly and cost-effectively. The corporation relies on the Integrated Drug Creation platform, which allows for reducing the time to clinical phases and increasing...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
